Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z

CDC Media Relations
Media Home | Contact Us
US Department of Health and Human Services logo and link

Media Relations Links
About Us
Media Contact
Frequently Asked Questions
Media Site Map

CDC News
Press Release Library
Transcripts
MMWR Summaries
B-Roll Footage
Upcoming Events

Related Links
Centers at CDC
Data and Statistics
Health Topics A-Z
Image Library
Publications, Software and Other Products
Global Health Odyssey
Find your state or local health department
HHS News
National Health Observances
Visit the FirstGov Web Site
Div. of Media Relations
1600 Clifton Road
MS D-14
Atlanta, GA 30333
(404) 639-3286
Fax (404) 639-7394


November 3, 2001/12:00 PM, ET
Contact: CDC Media Relations
(404) 639-3286

Press Release

CDC Update: Current Case Count, Telebriefings, and CDC Field Staff Status


CDC confirmed cases of anthrax

Summary of Local, State, and Federal Confirmed Human Cases and Exposures

Case Status Florida New York City New Jersey Washington, DC Total
Confirmed 2 5 5 5 17
    Cutaneous 0 4 3 0  
    Inhalational 2 1 2 5  
Suspect 0 3 2 0 5
    Cutaneous 0 3 2 0  
    Inhalational 0 0 0 0  
Total Cases         22

There have been 4 deaths associated with inhalational anthrax.

CDC confirmed cases are based on a rigorous case definition which was published in CDC’s Morbidity and Mortality Weekly Report (MMWR) on October 19, 2001.  The MMWR is available on-line at:  http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5041a1.htm.

CDC defines a confirmed case of anthrax as 1) a clinically compatible case of cutaneous, inhalational, or gastrointestinal illness that is laboratory confirmed by isolation of B. anthracis from an affected tissue or site or 2) other laboratory evidence of B. anthracis infection based on at least two supportive laboratory tests.  CDC defines a suspect case as 1) a clinically compatible case of illness without isolation of B. anthracis and no alternative diagnosis, but with laboratory evidence of B. anthracis by one supportive laboratory test or 2) a clinically compatible case of anthrax epidemiologically linked to a confirmed environmental exposure, but without corroborative laboratory evidence of B. anthracis infection.

CDC Telebriefings

Telebriefings regarding CDC activities and the anthrax investigations will be conducted during the entire month of November, on Monday through Friday, from Noon – 12:45 PM, EST.  The toll-free number for these briefings is 1–866–254–5942.

HHS/CDC staff deployment update (as of November 2, 2001)

Washington, D.C.

  • 23 EIS Officers
  • 17 Epidemiologists
  • 20 Industrial Hygienists
  •   3 Laboratorians
  •   4 Media Specialists
  •   2 National Pharmaceutical Stockpile staff
  •   4 Nurses
  • 10 Public Health Advisors
  •   5 Public Health Prevention Specialists
  •   1 Medical Officer

New Jersey

  • 10 EIS Officers
  •  6 Epidemiologists
  •  3 Industrial Hygienists
  •  3 Information Technology Specialists
  •  2 Public Health Prevention Specialists
  •  4 Public Health Advisors

New York City (Anthrax)

  • 20 EIS Officers
  • 10 Epidemiologists
  •   2 Industrial Hygienists
  •   5 Laboratorians
  •   1 Media Specialist
  •   5 Public Health Advisors
  •  1 Public Health Prevention Specialist

New York City (WTC)

  •  2 EIS Officers
  •  2 Industrial Hygienists

Florida

  • 2 EIS Officers
  • 3 Epidemiologists
  • 1 Industrial Hygienist
  • 2 Laboratorians
  • 1 Medical officer
  • 1 Public Health Advisor

For the latest update on CDC activities and on-going anthrax investigations visit www.bt.cdc.gov/ or www.cdc.gov/media/.


Media Home Page | Accessibility | Privacy Policy | Contact Us

CDC Home | Search | Health Topics A-Z

This page last updated November 3, 2001
URL:

United States Department of Health and Human Services
Centers for Disease Control and Prevention
Office of Communication
Division of Media Relations

Error processing SSI file
Error processing SSI file
Error processing SSI file